nezulcitinib   Click here for help

GtoPdb Ligand ID: 11304

Synonyms: example 1 [WO2020051105A1]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: The chemical structure for this Janus kinase inhibitor was obtained from the WHO's special release of proposed INNs for COVID-related therapeutics that was published in October 2020, with the proposed INN being nezulcitinib. The structure is a match to example 1 as claimed in Theravance's 2020 patent WO2020051105A1. Analysis of Theravance's pipeline webpage and ClinicalTrials.gov suggests that this is likely to be their clinical lead TD-0903, which they identify as a lung-selective JAK inhibitor, since TD-0903 had begun evaluation in COVID-19 patients. At the point of creating this entry (Nov 2020) there had been no formal name>structure disclosure. We will update this as further details become available.
In June 2021, Theravance announced that top-line results from patients with confirmed COVID-19 associated acute lung injury and impaired oxygenation, showed no statistically significant difference between nezulcitinib and placebo groups in terms of primary or secondary outcomes.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 104.38
Molecular weight 527.3
XLogP 4.36
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCc1cc(O)ccc1c1ccc2c(c1)[nH]nc2c1nc2c([nH]1)C[C@H](N(C2)C(C)C)C(=O)N1CC(C1)N(C)C
Isomeric SMILES CCc1cc(O)ccc1c1ccc2c(c1)[nH]nc2c1nc2c([nH]1)C[C@H](N(C2)C(C)C)C(=O)N1CC(C1)N(C)C
InChI InChI=1S/C30H37N7O2/c1-6-18-11-21(38)8-10-22(18)19-7-9-23-24(12-19)33-34-28(23)29-31-25-13-27(37(17(2)3)16-26(25)32-29)30(39)36-14-20(15-36)35(4)5/h7-12,17,20,27,38H,6,13-16H2,1-5H3,(H,31,32)(H,33,34)/t27-/m0/s1
InChI Key VQIIUJSNIKEMCK-MHZLTWQESA-N
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
[3-(dimethylamino)azetidin-1-yl]-[(6S)-2-[6-(2-ethyl-4-hydroxyphenyl)-1H-indazol-3-yl]-5-propan-2-yl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-6-yl]methanone
International Nonproprietary Names Click here for help
INN number INN
11732 nezulcitinib
Synonyms Click here for help
example 1 [WO2020051105A1]
Database Links Click here for help
CAS Registry No. 2412496-23-0 (source: WHO INN record)
GtoPdb PubChem SID 434321739
PubChem CID 146421275
Search Google for chemical match using the InChIKey VQIIUJSNIKEMCK-MHZLTWQESA-N
Search Google for chemicals with the same backbone VQIIUJSNIKEMCK
Search PubMed clinical trials nezulcitinib
Search PubMed titles nezulcitinib
Search PubMed titles/abstracts nezulcitinib
Search UniChem for chemical match using the InChIKey VQIIUJSNIKEMCK-MHZLTWQESA-N
Search UniChem for chemicals with the same backbone VQIIUJSNIKEMCK